MyHep-LVIR Tablets : MyLan's Generic Harvoni Achieves 96% Cure Rate in Patients With Hepatitis C

in genericharvoni •  7 years ago 

• Brand Name : MyHep-LVIR

• Active Ingredient : Ledipasvir 90 mg & Sofosbuvir 400 mg

• Manufacturer Company : Mylan Pharmaceutical

• Packaging Size : Pack of 28 Tablets

• Route of Administration : Oral

MyHep-LVIR Ledipasvir & Sofosbuvir HCV Treatment Medicine : Faster, Better Tolerated, Higher Cure Rates for All

Mylan NV, a global generic and specialty pharmaceuticals company, launched generic medicine Harvoni under the brand name MyHep LVIR. MyHep-LVIR tablet is a combination of Ledipasvir/Sofosbuvir and is indicated for the treatment of Hepatitis C infection. It offers a simplified Hepatitis C treatment regimen that eliminates the need for interferon and ribavirin

Treatment with MyHep-LVIR represented a dramatic shift in the approach to HCV therapy as it is a single pill taken once a day that effectively blocks HCV replication. The treatment course lasts from 8 to 24 weeks, depending on if a patient was previously treated unsuccessfully for HCV or if cirrhosis of the liver is present. Furthermore, it can be used for people who have HIV-HCV co-infection, cirrhosis, liver failure, and liver transplant, and it is very well tolerated. 

Although you get the desired effects of cure as a patient of HCV but it is also important for you to know the unwanted effects of this generic hepatitis medicine. Some of the more common side effects are cough, diarrhea, headache, irritability, strength loss, muscle pain, nausea, trouble in breathing and sleeping, unusual weakness or tiredness. Some of the less common side effects are discouragement, dizziness, sad feeling, empty feeling, appetite lacking, pleasure loss or interest loss and trouble when it comes to the concentration.

Note : This is in the list of prescription medicines and there is a requirement of the medical prescription for its dispensation.

MyHep-LVIR - 28 tablets bottle costs : $238.00 at Drugssquare.com 

Why many Hepatitis C patients from the USA, UK, Australia and Europe are looking for MyHep-LVIR when they have the original Harvoni? The main reason is - the cost of MyHep-LVIR. While Harvoni in the US costs $31,500 for standard 1-week treatment, its generic version costs less than $31,262 in India at Drugssquare.com. 

Although there is a major difference between the price of MyHep-LVIR and Harvoni but no difference in effectiveness. Generic medications have to be by regulation of equal effectiveness (measured by comparing bioavailability of both MyHep-LVIR and Harvoni) than the originals. In short, patients who are going to die without a cure, will rather seek out $238,00 cure than the $31,500. This is a big relief for the patient keeping in mind the extremely high price of the original Harvoni.

For more information, contact our customer service team and get personal help for all your product related queries. There are many ways you can get in touch with us -

Email : [email protected]

Mobile : +91-7777881188

Web : www.drugssquare.com

Authors get paid when people like you upvote their post.
If you enjoyed what you read here, create your account today and start earning FREE STEEM!
Sort Order:  

Epclusa is the world's first full oral, pan-genotypic, single-tablet hepatitis C treatment plan, once a day for all 6 genotypes (GT-1,-2,-3,-4,-5,-6) Treatment of hepatitis C patients.
https://www.medixocentre.com/epclusa-cost
https://www.medixocentre.com/epclusa-tablets
https://www.medixocentre.com/sofosbuvir-and-velpatasvir